Gracy Crane

452 total citations
13 papers, 226 citations indexed

About

Gracy Crane is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Gracy Crane has authored 13 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Economics and Econometrics. Recurrent topics in Gracy Crane's work include Lung Cancer Treatments and Mutations (9 papers), Advanced Breast Cancer Therapies (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Gracy Crane is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Advanced Breast Cancer Therapies (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Gracy Crane collaborates with scholars based in United Kingdom, Switzerland and France. Gracy Crane's co-authors include M J Cooper, W E G Thomas, R C N Williamson, Rachel Rosser, John Crammer, Mathieu Coudert, Paul Delmar, Reynaldo Martina, Walter Bordogna and Sophie Golding and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Gracy Crane

13 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gracy Crane United Kingdom 7 86 63 48 46 45 13 226
Shari Ludlam United States 2 42 0.5× 29 0.5× 30 0.6× 39 0.8× 62 1.4× 3 513
G. Amyotte Canada 4 56 0.7× 59 0.9× 30 0.6× 13 0.3× 83 1.8× 4 289
Ho Seok Chung South Korea 10 91 1.1× 133 2.1× 45 0.9× 17 0.4× 55 1.2× 48 320
Felicia Roncolato Australia 8 43 0.5× 55 0.9× 59 1.2× 75 1.6× 133 3.0× 31 247
Marguerite C. Lippert United States 8 78 0.9× 150 2.4× 38 0.8× 27 0.6× 84 1.9× 15 346
Natalie Hoog-Labouret France 7 16 0.2× 41 0.7× 37 0.8× 17 0.4× 69 1.5× 24 175
J. E. Altwein Germany 9 73 0.8× 202 3.2× 44 0.9× 13 0.3× 41 0.9× 49 353
Ciska Buijs Netherlands 9 21 0.2× 102 1.6× 12 0.3× 11 0.2× 207 4.6× 14 358
Aviva G. Asnis-Alibozek United States 5 23 0.3× 131 2.1× 68 1.4× 8 0.2× 170 3.8× 7 489
Mia Klinten Grand Denmark 8 27 0.3× 21 0.3× 33 0.7× 4 0.1× 21 0.5× 28 232

Countries citing papers authored by Gracy Crane

Since Specialization
Citations

This map shows the geographic impact of Gracy Crane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gracy Crane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gracy Crane more than expected).

Fields of papers citing papers by Gracy Crane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gracy Crane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gracy Crane. The network helps show where Gracy Crane may publish in the future.

Co-authorship network of co-authors of Gracy Crane

This figure shows the co-authorship network connecting the top 25 collaborators of Gracy Crane. A scholar is included among the top collaborators of Gracy Crane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gracy Crane. Gracy Crane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Crane, Gracy, John C. W. Lim, Churn‐Shiouh Gau, Jipan Xie, & Laura Chu. (2022). The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations. Current Medical Research and Opinion. 38(9). 1543–1551. 7 indexed citations
2.
Doebele, Robert C., Huong Trinh, Reynaldo Martina, et al.. (2021). Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC. Journal of Comparative Effectiveness Research. 10(17). 1271–1282. 14 indexed citations
3.
4.
Doebele, Robert C., Huong Trinh, Reynaldo Martina, et al.. (2019). P1.01-83 Comparative Efficacy Analysis Between Entrectinib Trial and Crizotinib Real-World ROS1 Fusion-Positive (ROS1+) NSCLC Patients. Journal of Thoracic Oncology. 14(10). S392–S392. 5 indexed citations
5.
Krebs, Matthew, Letizia Polito, Vlatka Smoljanović, Huong Trinh, & Gracy Crane. (2019). Treatment patterns and outcomes for patients (pts) with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) in US clinical practice. Annals of Oncology. 30. v636–v637. 2 indexed citations
6.
7.
Coudert, Mathieu, et al.. (2018). Real-world anaplastic lymphoma kinase (ALK) rearrangement testing patterns, treatment sequences, and survival of ALK inhibitor-treated patients. Current Medical Research and Opinion. 35(3). 535–542. 14 indexed citations
8.
Delmar, Paul, Mathieu Coudert, Walter Bordogna, et al.. (2018). Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib. Journal of Comparative Effectiveness Research. 7(9). 855–865. 48 indexed citations
9.
Martina, Reynaldo, Paul Delmar, Mathieu Coudert, et al.. (2017). Retrospective indirect comparison of alectinib phase II data vs ceritinib real-world data in ALK+ NSCLC after progression on crizotinib. Annals of Oncology. 28. ii36–ii36. 3 indexed citations
10.
11.
Thomas, W E G, et al.. (1984). TESTICULAR EXOCRINE MALFUNCTION AFTER TORSION. The Lancet. 324(8416). 1357–1360. 86 indexed citations
12.
Crammer, John, Rachel Rosser, & Gracy Crane. (1974). Blood Levels and Management of Lithium Treatment. BMJ. 3(5932). 650–654. 33 indexed citations
13.
Crane, Gracy, et al.. (1965). ACUTE FIBRINOLYSIS IN THE NEWBORN. The Lancet. 286(7414). 690–690. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shari Ludlam Breakdown of academic impact, for papers by G. Amyotte Breakdown of academic impact, for papers by Ho Seok Chung Breakdown of academic impact, for papers by Felicia Roncolato Breakdown of academic impact, for papers by Marguerite C. Lippert Breakdown of academic impact, for papers by Natalie Hoog-Labouret Breakdown of academic impact, for papers by J. E. Altwein Breakdown of academic impact, for papers by Ciska Buijs Breakdown of academic impact, for papers by Aviva G. Asnis-Alibozek Breakdown of academic impact, for papers by Mia Klinten Grand
Rankless by CCL
2026